- The report features Daewoong Pharmaceutical Co., Ltd.' s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons To Buy- Evaluate Daewoong Pharmaceutical Co., Ltd.' s strategic position with total access to detailed information on its product pipeline- Gain strategically significant competitor information, analysis, and insights to formulate effective R & D strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Identify and understand important and diverse types of therapeutics under development for Daewoong Pharmaceutical Co., Ltd.- Identify potential new clients or partners in the target demographic- Plan mergers and acquisitions effectively by identifying key players and it ' s most promising pipeline therapeutics- Devise corrective measures for pipeline projects by understanding Daewoong Pharmaceutical Co., Ltd.' s pipeline depth and focus of pipeline therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Buy a Sample copy of This Report @ http:// www. radiantinsights. com / research / daewoong-pharmaceutical-coltd-product-pipeline-review-2016 / request-sample
Table of Contents Table of Contents 2 List of Tables 6 List of Figures 6 Daewoong Pharmaceutical Co., Ltd. Snapshot 7 Daewoong Pharmaceutical Co., Ltd. Overview 7 Key Information 7 Key Facts 7 Daewoong Pharmaceutical Co., Ltd.- Research and Development Overview 8 Key Therapeutic Areas 8 Daewoong Pharmaceutical Co., Ltd.- Pipeline Review 11 Pipeline Products by Stage of Development 11 Pipeline Products- Monotherapy 12 Pipeline Products- Combination Treatment Modalities 13 Daewoong Pharmaceutical Co., Ltd.- Pipeline Products Glance 14 Daewoong Pharmaceutical Co., Ltd.- Late Stage Pipeline Products 14 Pre-Registration Products / Combination Treatment Modalities 14 Phase III Products / Combination Treatment Modalities 15 Daewoong Pharmaceutical Co., Ltd.- Clinical Stage Pipeline Products 16 Phase II Products / Combination Treatment Modalities 16 Phase I Products / Combination Treatment Modalities 17 Daewoong Pharmaceutical Co., Ltd.- Early Stage Pipeline Products 18 Preclinical Products / Combination Treatment Modalities 18 Discovery Products / Combination Treatment Modalities 19 Daewoong Pharmaceutical Co., Ltd.- Drug Profiles 20 DWJ-1261 20 Product Description 20 Mechanism of Action 20 R & D Progress 20 nepidermin 21 Product Description 21 Mechanism of Action 21